CAS: 17217-57-1; 4,4'-Dimethoxy-2,2'-Bipyridine

该化合物是一种有机化合物,其特点是双丙烯结构,由两个由碳-碳联系连接的环组成,由两个环组成,每个环的四处放置有两组甲状腺,这提高了其在有机溶剂中的溶解性,并可能影响其电子特性.该化合物通常表现出黄色到浅褐色的浅色外观,在极地有机溶剂中可以溶解.该化合物经常用于协调化学,特别是金属复合体中的悬浮物,因为其有能力从环的氮原子中捐献电子对配.该甲基氧子体的子体分体还可能影响化合物的再活动性和稳定性,使其在各种合成应用中具有兴趣.此外,4,4'-Dimethoxy-2,2'-bypypridridine可能表现出有趣的光物理特性,可在材料科学和有机电子中加以利用.在处理和储存时,应当参考安全数据,因为任何化学物质都是如此.

结构式图片

相似化合物

90770-88-0 2326-78-5 14162-97-1

欧盟法规

ECHA物质C&L通报

上下游产品

CAS号620-08-6 4-甲氧基吡啶 | CAS号84175-10-0 4,4'-dimethylox... | CAS号17228-69-2 2-氯-4-甲氧基吡啶 | CAS号51595-55-2 4,4'-二硝基-2,2'-联... | CAS号366-18-7 2,2'-联吡啶 | CAS号7275-43-6 N,N’-二氧化-2,2’-联吡啶 | CAS号174397-53-6 2,2'-联吡啶-4,4'-双磷酸二乙酯 | CAS号18511-71-2 4,4'-二溴-2,2'-联吡啶 | CAS号90770-88-0 4,4'-二羟基-2,2'-联吡啶

合成工艺路线路线简述

    4-甲氧基吡啶置于c30H50Ru3体系中,用 均三甲苯 用作溶剂,化学反应 100.0H,以8%的收率获得4,4'-二甲氧基-2,2'-联吡啶
    参考文献:含三桥联吡啶基配体的三钌配合物的合成及其向表面封端吡啶和垂直配位的吡啶基配体的转化
    标题:含三桥联吡啶基配体的三钌配合物的合成及其向表面封端吡啶和垂直配位的吡啶基配体的转化
    摘要:不同于羰基簇的用吡啶导致μ吡啶基复合体的形成的反应中,羰基三钌pentahydrido络合物的反应{的cp *茹(μ-H)} 3(μ 3-H)2(cp * =η 5-ç 5我5)(1)其中μ提供吡啶3-η 2(//)-吡啶基配合物,(的cp * Ru)的3(μ-H)4(μ 3-η 2(//)-Rc 5 ħ 3 N)(2A,R = H; 2B,R = 4-Coome; 2C,R = 4-Cooet; 2D,R = 4-Me; 在图2E中,R = 5-Me),其中吡啶基的分子平面相对于ru 3平面倾斜.三金属核的富电子金属中心使得能够向吡啶基基团进行反向供电,这导致了c═n键的额外π配位.的富电子的金属中心2A-2C中也促进了进一步转化成面对封盖的吡啶复合物{的cp *茹(μ-H)} 3(μ 3-η 2:η 2:η 2-Rc 5 H ^ 4 N) (3A,R = H; 3B,R
    Doi:10.1021/om300379D

    海关参考信息

    专利信息


    专利号:US-8153839-B2
    优先权日:2005-09-14
    标题:Method for synthesis of keto acids or amino acids by hydration of acetylene compound
    发明人:OGO SEIJI; FUKUZUMI SHUN-ICHI
    权利人:OGO SEIJI; FUKUZUMI SHUN-ICHI; JAPAN SCIENCE & TECH AGENCY
    摘要:An object of the present invention is to provide a method for synthesis of keto acids by hydration of an acetylene compound (acetylene-carboxylic acids) under mild conditions free from harmful mercury catalysts and a method for synthesis of amino acids from acetylene-carboxylic acids in a single container (one-pot or tandem synthesis). In one embodiment of the method according to the present invention for synthesis of keto acids, acetylene-carboxylic acids is hydrated in the presence of a metal salt represented by General Formula (1), n nwhere M 1 represents an element in Group VIII, IX, or X of the periodic table, and X 1 , X 2 , or X 3 ligand represents halogen, H 2 O, or a solvent molecule, and k represents a valence of a cation species, and Y represents an anion species, and L represents a valence of the anion species, and each of K and L independently represents 1 or 2, and k×m=L×n.

    专利号:WO-2023122754-A1
    优先权日:2021-12-23
    标 题 :Processes and intermediates for preparing gb13, gb22 and himgaline
    发明人:LANDWEHR ELEANOR; SHENVI RYAN; BAKER MEGHAN; OGUMA TAKUYA
    权利人:SCRIPPS RESEARCH INST
    摘要:Provided herein are processes for the streamlined synthesis of Galbulimima alkaloids, such as himbadine, isolated from Galbulimima belgraveana and G. baccatta, trees endemic to the rainforests of Northern Australia and Papua New Guinea, as well as analogs thereof, such as GB13, GB16, GB22, and himgaline, and further including intermediates useful in the synthesis of these and related compounds.

    专利号:US-12173012-B2
    优先权日:2020-07-02
    标题:Indolocarbazole analogs of staurosporine and methods of synthesis thereof
    发明人:WOOD JOHN L; KONG KE; GAYLER KEVIN
    权利人:UNIV BAYLOR
    摘要:Equipotent indolocarbazole-derived analogs of staurosporine identified herein are prepared through C—H borylation chemistry. Functionality resides at C2 and C10 of the indolocarbazole aromatic region. Introducing functionality in this previously inaccessible region does not abrogate kinase activity and is shown to change the selectivity profile.

    专利号:US-10793557-B2
    优先权日:2018-04-03
    标题 :Sting agonist compounds
    发明人:ALTMAN MICHAEL D; CASH BRANDON D; CHILDERS MATTHEW LLOYD; CUMMING JARED N; DEMONG DUANE E; HAIDLE ANDREW MARC; HENDERSON TIMOTHY J; JEWELL JAMES P; LARSEN MATTHEW A; LIM JONGWON; LU MIN; OTTE RYAN D; TROTTER BENJAMIN WESLEY
    权利人:MERCK SHARP & DOHME
    摘要:Compounds of general formula (I), of general formula (II), of general formula (III), of general formula (IV), of general formula (V), of general formula (VI), and their pharmaceutically acceptable salts, wherein all variables are defined herein, that may be useful as inductors of type I interferon production, specifically as STING active agents, are provided. Also provided are compositions comprising such compounds, processes for the synthesis of such compounds, and to uses of such compounds, including administration of such compounds to induce immune response, to induce STING-dependent type I interferon production, and/or to treat a cell proliferation disorder, such as cancer.

    专利号:US-2024360125-A9
    优先权日:2021-02-22
    标 题 :2-substituted bicyclo[1.1.1]pentanes
    发明人:MACMILLAN DAVID W; GARRY OLIVIA L; LIANG YUFAN; HEILMANN MICHAEL
    权利人:UNIV PRINCETON
    摘要:Provided herein are 2-substituted bicyclo[1.1.1]pentane (BCP) compounds, as well as methods of making the 2-substituted BCP compounds and methods of derivatizing the 2-substituted BCP compounds, particularly at the 2-position. The 2-substituted BCP compounds described herein are useful building blocks in the synthesis of a variety of products, including pharmaceuticals, polymers, liquid crystals, monolayers and supramolecular structures.

    专利号:EP-1932824-A1
    优先权日:2005-09-14
    标题:Method for synthesis of keto acid or amino acid by hydration of acethylene compound
    无锡弗里斯特生物科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.wxforest.com
    电话: 0086(519)8387-9978👤
    📞无锡弗里斯特生物科技有限公司 ⚠️参考联系方式

    销售电话:0086(519)8387-9978
    邮箱:sales@chemsanyou.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    武汉华玖医药科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.whhjpharm.com
    企业联系电话:18120446293👤
    📞武汉华玖医药科技有限公司 ⚠️参考联系方式
    联系人:汪经理
    电话:18120446293
    手机:18120446293
    传真:027-59220200
    邮箱:3504472216@qq.com
    通信地址: 武汉市东西湖区泾河办事处陈家岭189号
    邮编: 432000
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:武汉市东西湖区泾河办事处陈家岭189号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Zhang, Q.-W.; An, K.; He, W., Science of Synthesis Knowledge Updates, (2020) 3, 33.
    摘要:Huy, P.; Czekelius, C., Science of Synthesis Knowledge Updates, (2019) 2, 216.
    摘要:Jie, X.; Su, W., Science of Synthesis, (2022) , 36.
    摘要:Szabó, K. J., Science of Synthesis: Cross Coupling and Heck-Type Reactions, (2012) 2, 491.
    摘要:Nakao, Y., Science of Synthesis: Catalytic Transformations via CH Activation, (2015) 1, 407.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知